These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30220705)

  • 1. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.
    Gray E; Marti J; Brewster DH; Wyatt JC; Hall PS;
    Br J Cancer; 2018 Oct; 119(7):808-814. PubMed ID: 30220705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based validation of the prognostic model PREDICT for early breast cancer.
    Wishart GC; Bajdik CD; Azzato EM; Dicks E; Greenberg DC; Rashbass J; Caldas C; Pharoah PD
    Eur J Surg Oncol; 2011 May; 37(5):411-7. PubMed ID: 21371853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the online prediction model CancerMath in the Dutch breast cancer population.
    Hoveling LA; van Maaren MC; Hueting T; Strobbe LJA; Hendriks MP; Sonke GS; Siesling S
    Breast Cancer Res Treat; 2019 Dec; 178(3):665-681. PubMed ID: 31471837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer.
    Stabellini N; Cao L; Towe CW; Miller ME; Sousa-Santos AH; Amin AL; Montero AJ
    J Natl Compr Canc Netw; 2023 Oct; 21(10):1011-1019.e6. PubMed ID: 37856198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
    Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
    Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia.
    Miao H; Hartman M; Verkooijen HM; Taib NA; Wong HS; Subramaniam S; Yip CH; Tan EY; Chan P; Lee SC; Bhoo-Pathy N
    BMC Cancer; 2016 Oct; 16(1):820. PubMed ID: 27769212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients.
    Zaguirre K; Kai M; Kubo M; Yamada M; Kurata K; Kawaji H; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Morisaki T; Mori H; Oda Y; Chen S; Moriyama T; Shimizu S; Nakamura M
    Cancer Med; 2021 Mar; 10(5):1605-1613. PubMed ID: 33452761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
    Wishart GC; Azzato EM; Greenberg DC; Rashbass J; Kearins O; Lawrence G; Caldas C; Pharoah PD
    Breast Cancer Res; 2010; 12(1):R1. PubMed ID: 20053270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a new predictive model for breast cancer survival in New Zealand and comparison to the Nottingham prognostic index.
    Elwood JM; Tawfiq E; TinTin S; Marshall RJ; Phung TM; Campbell I; Harvey V; Lawrenson R
    BMC Cancer; 2018 Sep; 18(1):897. PubMed ID: 30223800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascertainment of breast cancer by the Scottish Cancer Registry: an assessment based on comparison with five independent breast cancer trials databases.
    Brewster DH; Stockton DL
    Breast; 2008 Feb; 17(1):104-6. PubMed ID: 17855094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
    Wang Y; Broeks A; Giardiello D; Hauptmann M; Jóźwiak K; Koop EA; Opdam M; Siesling S; Sonke GS; Stathonikos N; Ter Hoeve ND; van der Wall E; van Deurzen CHM; van Diest PJ; Voogd AC; Vreuls W; Linn SC; Dackus GMHE; Schmidt MK
    Eur J Cancer; 2023 Dec; 195():113401. PubMed ID: 37925965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath.
    Karapanagiotis S; Pharoah PDP; Jackson CH; Newcombe PJ
    Clin Cancer Res; 2018 May; 24(9):2110-2115. PubMed ID: 29444929
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women.
    Nickson C; Procopio P; Velentzis LS; Carr S; Devereux L; Mann GB; James P; Lee G; Wellard C; Campbell I
    Breast Cancer Res; 2018 Dec; 20(1):155. PubMed ID: 30572910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidimensional Machine Learning Personalized Prognostic Model in an Early Invasive Breast Cancer Population-Based Cohort in China: Algorithm Validation Study.
    Zhong X; Luo T; Deng L; Liu P; Hu K; Lu D; Zheng D; Luo C; Xie Y; Li J; He P; Pu T; Ye F; Bu H; Fu B; Zheng H
    JMIR Med Inform; 2020 Nov; 8(11):e19069. PubMed ID: 33164899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands.
    van Steenbeek CD; van Maaren MC; Siesling S; Witteveen A; Verbeek XAAM; Koffijberg H
    BMC Med Res Methodol; 2019 Jun; 19(1):117. PubMed ID: 31176362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients.
    Piñero-Madrona A; Ripoll-Orts F; Sánchez-Méndez JI; Chaves-Benito A; Gómez-de la Bárcena MR; Calatrava-Fons A; Menjón-Beltrán S; Peg-Cámara V
    Breast Cancer Res Treat; 2020 Jun; 181(2):339-345. PubMed ID: 32253684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.
    Candido Dos Reis FJ; Wishart GC; Dicks EM; Greenberg D; Rashbass J; Schmidt MK; van den Broek AJ; Ellis IO; Green A; Rakha E; Maishman T; Eccles DM; Pharoah PDP
    Breast Cancer Res; 2017 May; 19(1):58. PubMed ID: 28532503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.